MentionFox
Home › funding signals › Enveric Biosciences, Inc.
Company · SEC filings

Enveric Biosciences, Inc. funding history

Enveric Biosciences, Inc. has 5 Form D filings on record, from 2023-04-19 to 2026-05-04. Together its new offerings report $6.56M sold.

Funding historyFounders and team

What do you want to do with Enveric Biosciences, Inc.?

Based
CAMBRIDGE, MASSACHUSETTS
Industry group
Biotechnology
Filings
5
Raised (new offerings)
$6.56M

Every filing

FiledTypeAmount soldTotal offeringRecords
2026-05-04New offering
first sale 2026-04-17
$5M$5MSEC filing
2026-02-11New offering
first sale 2026-01-28
$1.45M$1.45MSEC filing
2025-12-23New offering
first sale 2025-12-12
$107K$107KSEC filing
2025-10-03New offering
first sale 2025-09-18
$0—SEC filing
2023-04-19Amendment——SEC filing

How the total is counted: the amount sold on each new offering, added together. Amendments are left out, because an amendment restates an offering already counted. A filing whose figures have not been read yet shows a dash and adds nothing.

Every figure here is read from Enveric Biosciences, Inc.'s own filings with the SEC. The people those filings name are on the team page.

Cite this page

Permanent URL: https://mentionfox.com/company/enveric-biosciences-inc
Last updated 2026-09-26
Primary record: SEC filing 1 · SEC filing 2 · SEC filing 3 · SEC filing 4
Enveric Biosciences, Inc. funding history: 5 SEC filings, $6.56M raised. MentionFox, 2026-09-26. https://mentionfox.com/company/enveric-biosciences-inc